1. K. O. Borg, E. Carlsson, K.-J. Hoffmann, T.-E. Jönsson, H. Thorin, and B. Wallin. Metabolism of metoprolol-(3H) in man, the dog and the rat.Acta Pharmacol. Toxicol. 36:125–135 (Suppl. 5) (1975).
2. L. Jordö, P. O. Attman, M. Aurell, L. Johansson, G. Johnsson, and C.-G. Regårdh. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.Clin. Pharmacokin. (in press).
3. K.-J. Hoffmann, C.-G. Regårdh, M. Aurell, M. Ervik, and L. Jordö. The effect of impaired renal function on the plasma levels and urinary excretion of metoprolol metabolites.Clin. Pharmacokin. (in press).
4. K. O. Borg, E. Fellenius, R. Johansson, and M. Wallborg. Pharmacokinetic studies of metoprolol-(3H) in the rat and in the dog.Acta Pharmacol. Toxicol. 36:104–115 (Suppl. 5) (1975).
5. M. Ervik, K.-J. Hoffmann, and K. Kylberg-Hansen. Multiple ion monitoring of metoprolol and two metabolites in plasma and urine with deuterated internal standards.Biomed. Mass Spectrom. (to be published).